1317.9000 -7.40 (-0.56%)
NSE Jun 23, 2025 15:31 PM
Volume: 843.9K
 

logo
Dr. Reddy's Laboratories Ltd.
24 Jan 2025, 12:00AM
1317.90
-0.56%
Emkay
Adjusted for the milestone payment received from Journey Medical Corp, 3QFY25 EBITDA for Dr Reddy’s was below street/our estimates. The PAT miss was higher on account of lower other income.
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended